Keiran S. M. Smalley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Keiran S. M. Smalley has a total of 843 co-authors. Here are the top co-authors by number of shared publications:
- Yian Ann Chen
University of Utah 3 Department of Biostatistics Salt Lake City, Utah
55 shared publications - John Matthew Koomen
Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
48 shared publications - J. William Harbour
Department of Ophthalmology and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
35 shared publications - Jonathan D. Licht
University of Florida Health Sciences Center, Gainesville, Florida
35 shared publications - Paulo C. Rodriguez
Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, USA
34 shared publications Jiannong Li
Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
32 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 9 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Western blots showing knockdown of shGDF15 in uveal melanoma cells
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 9 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Western blots showing knockdown of shGDF15 in uveal melanoma cells
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Growth factor array from uveal melanoma monoculture and uveal melanoma-hepatic stellate cell co-culture
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Growth factor array from uveal melanoma monoculture and uveal melanoma-hepatic stellate cell co-culture
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 14 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Experimental schema of the eye-liver metastasis model
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 14 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Experimental schema of the eye-liver metastasis model
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 6 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Western blot showing Osteopontin does not increase COL1A1 expression in hepatic stellate cells
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 6 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Western blot showing Osteopontin does not increase COL1A1 expression in hepatic stellate cells
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Genetic profiling of the uveal melanoma cell lines used in the study
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Genetic profiling of the uveal melanoma cell lines used in the study
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Data from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Uveal melanoma is an aggressive tumor type that frequently results in fatal liver metastasis. A better understanding of the interactions between uveal melanoma and host cells in the tumor microenvironment that promote liver metastasis could lead to the development of therapeutic strategies. In this study, we used single-cell RNA-sequencing analysis of uveal melanoma–hepatic stellate cell (HSC) cocultures to explore the mechanisms by which uveal melanoma cells metastasize to the liver. HSCs enriched for uveal melanoma cell states that expressed genes implicated in cell survival, metabolic reprogramming, and growth differentiation factor 15 (GDF15)–mediated angiogenesis. The TGFβ family member GDF15 was associated with a metastatic uveal melanoma phenotype. Silencing of BAP1 in uveal melanoma cells led to increased GDF15 expression and accumulation of H3K27ac marks at the GDF15 promoter. Treatment of HSCs with GDF15 led to increased expression of extracellular matrix (ECM) proteins, inflammatory cytokines, and angiogenic factors, including IL8. Both exogenous GDF15 and IL8, as well as conditioned media from uveal melanoma–HSC cocultures, increased endothelial cell network formation in vitro, an effect that was blocked by anti-GDF15 antibodies. In multiple models of metastatic uveal melanoma, silencing of GDF15 inhibited the outgrowth of metastatic lesions, associated with reduced deposition of ECM and recruitment of endothelial cells. Together, these findings reveal that uveal melanoma liver metastasis development is dependent on GDF15-mediated remodeling of the liver microenvironment, which leads to an angiogenic response and matrix deposition that supports tumor growth. Significance:GDF15 functions as a growth factor that helps drive the development of liver metastases in uveal melanoma by contributing to angiogenesis and matrix deposition, allowing for metastatic outgrowth.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Uveal melanoma is an aggressive tumor type that frequently results in fatal liver metastasis. A better understanding of the interactions between uveal melanoma and host cells in the tumor microenvironment that promote liver metastasis could lead to the development of therapeutic strategies. In this study, we used single-cell RNA-sequencing analysis of uveal melanoma–hepatic stellate cell (HSC) cocultures to explore the mechanisms by which uveal melanoma cells metastasize to the liver. HSCs enriched for uveal melanoma cell states that expressed genes implicated in cell survival, metabolic reprogramming, and growth differentiation factor 15 (GDF15)–mediated angiogenesis. The TGFβ family member GDF15 was associated with a metastatic uveal melanoma phenotype. Silencing of BAP1 in uveal melanoma cells led to increased GDF15 expression and accumulation of H3K27ac marks at the GDF15 promoter. Treatment of HSCs with GDF15 led to increased expression of extracellular matrix (ECM) proteins, inflammatory cytokines, and angiogenic factors, including IL8. Both exogenous GDF15 and IL8, as well as conditioned media from uveal melanoma–HSC cocultures, increased endothelial cell network formation in vitro, an effect that was blocked by anti-GDF15 antibodies. In multiple models of metastatic uveal melanoma, silencing of GDF15 inhibited the outgrowth of metastatic lesions, associated with reduced deposition of ECM and recruitment of endothelial cells. Together, these findings reveal that uveal melanoma liver metastasis development is dependent on GDF15-mediated remodeling of the liver microenvironment, which leads to an angiogenic response and matrix deposition that supports tumor growth. Significance:GDF15 functions as a growth factor that helps drive the development of liver metastases in uveal melanoma by contributing to angiogenesis and matrix deposition, allowing for metastatic outgrowth.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 15 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Examination of other mouse organs to identify the presence of macrometastases (H&E)
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 15 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Examination of other mouse organs to identify the presence of macrometastases (H&E)
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
GDF15 expression in normal tissues and cancer
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
GDF15 expression in normal tissues and cancer
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 7 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Vascular network formation in presence of GDF15
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 7 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Vascular network formation in presence of GDF15
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 17 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Western blot data showing human recombinant GDF15 stimulation on mouse HSCs
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 17 from GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma
Western blot data showing human recombinant GDF15 stimulation on mouse HSCs